Description: MaxCyte is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. MaxCyte licenses has granted 13 strategic platform licenses to commercial cell therapy developers that allow for more than 75 clinical programs.
Business Profile
